Murphy & Mullick Capital Management Corp
Position in ABT — Abbott Laboratories
CIK 2047271
SMITHTOWN, NY
Position in ABT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$340,547
-$88,202 QoQ
Shares Held
3,753
-10.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
#2,185
of 2,951 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABT Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Murphy & Mullick Capital Management Corp holds $630,415 across 10 Medical Devices names. ABT ranks #1 (54.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
This page
|
3,753 | $340,547 | |
| 2 | SYK |
Stryker Corp
|
308 | $96,970 | |
| 3 | MDT |
Medtronic plc
|
781 | $61,097 | |
| 4 | ZBH |
Zimmer Biomet Holdings, Inc.
|
596 | $51,309 | |
| 5 | PODD |
Insulet Corp
|
325 | $49,481 | |
| 6 | STE |
STERIS plc
|
39 | $8,212 | |
| 7 | GKOS |
GLAUKOS Corp
|
50 | $6,988 | |
| 8 | GEHC |
GE HealthCare Technologies Inc.
|
105 | $6,721 |
All Filings in ABT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $340,547 | 3,753 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $428,749 | 4,176 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $610,663 | 4,874 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $667,423 | 4,983 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $698,819 | 5,138 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $681,555 | 5,138 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $600,048 | 5,305 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||